Entity

Stage

A stage is a distinct phase or step in a process, such as a clinical trial, funding round, or review, that marks a significant point of progression or evaluation.

Why it’s in the news: It is in the news due to its role in high-stakes developments, including a failed drug study, a quantum computing competition, and a trade agreement review.

Latest on Stage

  • STAT+: Argenx sees unusual setback with failure of late-stage study of drug for autoimmune disease
  • DARPA moves Atom Computing, IBM, IonQ and Diraq to final quantum test stage
  • From Elvis to Oppenheimer, global ghosts sing noh on the Tokyo theater stage
  • Late Stage Funding Dips, Swish Takes On Zomato & More
  • USTR initiates next stage of USMCA review
  • Why Growth Stage Startup Funding Outpaced Late Stage Investments In Q3

Connections

7 entities linked to Stage across the news graph.